Kortekaas R - Search Results

1

Blood-brain barrier dysfunction in parkinsonian midbrain in vivo.

Kortekaas R, Leenders KL, van Oostrom JC, Vaalburg W, Bart J, Willemsen AT, Hendrikse NH. Kortekaas R, et al. Ann Neurol. 2005 Feb;57(2):176-9. doi: 10.1002/ana.20369. Ann Neurol. 2005. PMID: 15668963

2

Blood-brain barrier P-glycoprotein function decreases in specific brain regions with aging: a possible role in progressive neurodegeneration.

Bartels AL, Kortekaas R, Bart J, Willemsen AT, de Klerk OL, de Vries JJ, van Oostrom JC, Leenders KL. Bartels AL, et al. Among authors: kortekaas r. Neurobiol Aging. 2009 Nov;30(11):1818-24. doi: 10.1016/j.neurobiolaging.2008.02.002. Epub 2008 Mar 20. Neurobiol Aging. 2009. PMID: 18358568

3

Decreased blood-brain barrier P-glycoprotein function in the progression of Parkinson's disease, PSP and MSA.

Bartels AL, Willemsen AT, Kortekaas R, de Jong BM, de Vries R, de Klerk O, van Oostrom JC, Portman A, Leenders KL. Bartels AL, et al. Among authors: kortekaas r. J Neural Transm (Vienna). 2008 Jul;115(7):1001-9. doi: 10.1007/s00702-008-0030-y. Epub 2008 Feb 12. J Neural Transm (Vienna). 2008. PMID: 18265929 Free PMC article.

4

11C-verapamil to assess P-gp function in human brain during aging, depression and neurodegenerative disease.

Bartels AL, de Klerk OL, Kortekaas R, de Vries JJ, Leenders KL. Bartels AL, et al. Among authors: kortekaas r. Curr Top Med Chem. 2010;10(17):1775-84. doi: 10.2174/156802610792928059. Curr Top Med Chem. 2010. PMID: 20645917 Review.

5

Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein.

de Vries EF, Kortekaas R, van Waarde A, Dijkstra D, Elsinga PH, Vaalburg W. de Vries EF, et al. Among authors: kortekaas r. J Nucl Med. 2005 Aug;46(8):1384-92. J Nucl Med. 2005. PMID: 16085598 Free article.

6

In vivo binding behavior of dopamine receptor agonist (+)-PD 128907 and implications for the "ceiling effect" in endogenous competition studies with [(11)C]raclopride-a positron emission tomography study in Macaca mulatta.

Kortekaas R, Maguire RP, Cremers TI, Dijkstra D, van Waarde A, Leenders KL. Kortekaas R, et al. J Cereb Blood Flow Metab. 2004 May;24(5):531-5. doi: 10.1097/00004647-200405000-00007. J Cereb Blood Flow Metab. 2004. PMID: 15129185

7

Despite irreversible binding, PET tracer [11C]-SA5845 is suitable for imaging of drug competition at sigma receptors-the cases of ketamine and haloperidol.

Kortekaas R, Maguire RP, van Waarde A, Leenders KL, Elsinga PH. Kortekaas R, et al. Neurochem Int. 2008 Jul;53(1-2):45-50. doi: 10.1016/j.neuint.2008.04.010. Epub 2008 May 13. Neurochem Int. 2008. PMID: 18571772

8

Prefrontal cortex and striatal activation by feedback in Parkinson's disease.

Keitz M, Koerts J, Kortekaas R, Renken R, de Jong BM, Leenders KL. Keitz M, et al. Among authors: kortekaas r. Brain Res. 2008 Oct 21;1236:225-33. doi: 10.1016/j.brainres.2008.07.110. Epub 2008 Aug 7. Brain Res. 2008. PMID: 18718454

9

Development of an inexpensive, low attenuation styrofoam primate chair for use in a PET scanner.

Kortekaas R, van Waarde A, Maguire RP, Leenders KL, Elsinga PH. Kortekaas R, et al. J Med Primatol. 2004 Apr;33(2):78-82. doi: 10.1111/j.1600-0684.2004.00056.x. J Med Primatol. 2004. PMID: 15061720

10

Motor behavior correlates with striatal [¹⁸F]-DOPA uptake in MPTP-lesioned primates.

Kortekaas R, Eshuis SA, Andringa G, Cools AR, Leenders KL. Kortekaas R, et al. Neurochem Int. 2013 Mar;62(4):349-53. doi: 10.1016/j.neuint.2013.01.021. Epub 2013 Jan 26. Neurochem Int. 2013. PMID: 23357476

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

116 results

Search Page

Filters